{"entity":{"type":"insider","cik":"0001742765","url":"/insider/0001742765","json_url":"/insider/0001742765.json","name":"Atlas Venture Associates X, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":120,"n_filings":20,"first":"2019-03-22","last":"2024-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Atlas Venture Associates X, LLC","source":"filing","n_filings":20,"first_seen":"2019-03-22","last_seen":"2024-03-13"}],"transactions":[{"id":2130872,"accession":"0001415889-24-007894","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001415889-24-007894","line_url":"/filing/0001415889-24-007894","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Associates X, LLC; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Associates Opportunity I, LLC","owner_display_name":"Atlas Venture Opportunity Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139255.0,"shares_display":"139,255","price_per_share":42.227677641736385,"price_display":"42.23","price_state":"stated","total_value":5880415.25,"total_display":"5,880,415.25","total_whole":"5,880,415","shares_owned_after":4682761.0,"shares_owned_after_display":"4,682,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-13","scope":"insider","n_lines":4},{"id":2130856,"accession":"0001415889-24-007894","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-007894","line_url":"/filing/0001415889-24-007894","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Associates X, LLC; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Associates Opportunity I, LLC","owner_display_name":"Atlas Venture Opportunity Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162918.0,"shares_display":"162,918","price_per_share":41.977024760922674,"price_display":"41.98","price_state":"stated","total_value":6838812.92,"total_display":"6,838,812.92","total_whole":"6,838,813","shares_owned_after":4799746.0,"shares_owned_after_display":"4,799,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-13","scope":"insider","n_lines":4},{"id":2130842,"accession":"0001415889-24-007894","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-007894","line_url":"/filing/0001415889-24-007894","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Associates X, LLC; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Associates Opportunity I, LLC","owner_display_name":"Atlas Venture Opportunity Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51184.0,"shares_display":"51,184","price_per_share":42.84831646608315,"price_display":"42.85","price_state":"stated","total_value":2193148.23,"total_display":"2,193,148.23","total_whole":"2,193,148","shares_owned_after":4930934.0,"shares_owned_after_display":"4,930,934","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider","n_lines":4},{"id":2178391,"accession":"0001209191-24-002231","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-002231","line_url":"/filing/0001209191-24-002231","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates Opportunity II, LP; Atlas Venture Associates Opportunity I, LLC; Atlas Venture Opportunity Fund II, L.P.; Atlas Venture Associates Opportunity II, LLC; Atlas Venture Fund X, L.P.","owner_display_name":"Atlas Venture Associates X, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":67.65,"price_display":"67.65","price_state":"stated","total_value":10147500.0,"total_display":"10,147,500.00","total_whole":"10,147,500","shares_owned_after":703660.0,"shares_owned_after_display":"703,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-25","scope":"insider","n_lines":3},{"id":2424022,"accession":"0001209191-24-001540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001540","line_url":"/filing/0001209191-24-001540","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates Opportunity I, LLC; Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Fund X, L.P.; Atlas Venture Associates Opportunity I, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Associates X, LLC","owner_display_name":"Atlas Venture Associates Opportunity I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":3200000.0,"total_display":"3,200,000.00","total_whole":"3,200,000","shares_owned_after":1449686.0,"shares_owned_after_display":"1,449,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-12","scope":"insider","n_lines":2},{"id":8754150,"accession":"0001209191-23-058707","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-23-058707","line_url":"/filing/0001209191-23-058707","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates Opportunity I, LLC; Atlas Venture Fund X, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, L.P.","owner_display_name":"Atlas Venture Associates Opportunity I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51374.0,"shares_display":"51,374","price_per_share":58.27858410869311,"price_display":"58.28","price_state":"stated","total_value":2994003.98,"total_display":"2,994,003.98","total_whole":"2,994,004","shares_owned_after":1479866.0,"shares_owned_after_display":"1,479,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-14","scope":"insider","n_lines":4},{"id":8754142,"accession":"0001209191-23-058707","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-23-058707","line_url":"/filing/0001209191-23-058707","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates Opportunity I, LLC; Atlas Venture Fund X, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, L.P.","owner_display_name":"Atlas Venture Associates Opportunity I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8871.0,"shares_display":"8,871","price_per_share":59.995749070003384,"price_display":"60.00","price_state":"stated","total_value":532222.29,"total_display":"532,222.29","total_whole":"532,222","shares_owned_after":1510571.0,"shares_owned_after_display":"1,510,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider","n_lines":4},{"id":8754128,"accession":"0001209191-23-058707","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-23-058707","line_url":"/filing/0001209191-23-058707","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates Opportunity I, LLC; Atlas Venture Fund X, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, L.P.","owner_display_name":"Atlas Venture Associates Opportunity I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129918.0,"shares_display":"129,918","price_per_share":62.796226235009776,"price_display":"62.80","price_state":"stated","total_value":8158360.12,"total_display":"8,158,360.12","total_whole":"8,158,360","shares_owned_after":1562550.0,"shares_owned_after_display":"1,562,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-14","scope":"insider","n_lines":14},{"id":8753361,"accession":"0001209191-23-049778","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-049778","line_url":"/filing/0001209191-23-049778#line-3","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Fund X, L.P.; Atlas Venture Associates X, LLC; ATLAS VENTURE ASSOCIATES X, L.P.","owner_display_name":"Atlas Venture Fund X, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2115.0,"shares_display":"2,115","price_per_share":53.22,"price_display":"53.22","price_state":"stated","total_value":112560.3,"total_display":"112,560.30","total_whole":"112,560","shares_owned_after":1593785.0,"shares_owned_after_display":"1,593,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-16","filed_date":"2023-09-18","scope":"insider"},{"id":8753358,"accession":"0001209191-23-049778","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-049778","line_url":"/filing/0001209191-23-049778#line-2","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Fund X, L.P.; Atlas Venture Associates X, LLC; ATLAS VENTURE ASSOCIATES X, L.P.","owner_display_name":"Atlas Venture Fund X, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":260894.0,"shares_display":"260,894","price_per_share":53.16,"price_display":"53.16","price_state":"stated","total_value":13869125.04,"total_display":"13,869,125.04","total_whole":"13,869,125","shares_owned_after":1595900.0,"shares_owned_after_display":"1,595,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8753355,"accession":"0001209191-23-049778","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049778","line_url":"/filing/0001209191-23-049778#line-1","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Fund X, L.P.; Atlas Venture Associates X, LLC; ATLAS VENTURE ASSOCIATES X, L.P.","owner_display_name":"Atlas Venture Fund X, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94440.0,"shares_display":"94,440","price_per_share":53.05,"price_display":"53.05","price_state":"stated","total_value":5010042.0,"total_display":"5,010,042.00","total_whole":"5,010,042","shares_owned_after":1856794.0,"shares_owned_after_display":"1,856,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":8630085,"accession":"0001209191-23-046110","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-046110","line_url":"/filing/0001209191-23-046110","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates Opportunity I, LLC; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Fund X, L.P.; Atlas Venture Opportunity Fund I, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.","owner_display_name":"Atlas Venture Associates Opportunity I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184000.0,"shares_display":"184,000","price_per_share":52.4,"price_display":"52.40","price_state":"stated","total_value":9641600.0,"total_display":"9,641,600.00","total_whole":"9,641,600","shares_owned_after":1951234.0,"shares_owned_after_display":"1,951,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-16","scope":"insider","n_lines":2},{"id":8630081,"accession":"0001209191-23-046110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-046110","line_url":"/filing/0001209191-23-046110","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Disc Medicine, Inc.","issuer_ticker":"IRON","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Associates Opportunity I, LLC; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Fund X, L.P.; Atlas Venture Opportunity Fund I, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.","owner_display_name":"Atlas Venture Associates Opportunity I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":52.592,"price_display":"52.59","price_state":"stated","total_value":9203600.0,"total_display":"9,203,600.00","total_whole":"9,203,600","shares_owned_after":2064303.0,"shares_owned_after_display":"2,064,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-14","filed_date":"2023-08-16","scope":"insider","n_lines":3},{"id":7809302,"accession":"0001209191-23-003293","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-003293","line_url":"/filing/0001209191-23-003293","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates Opportunity I, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, LLC; Atlas Venture Fund X, L.P.","owner_display_name":"Atlas Venture Opportunity Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98720.0,"shares_display":"98,720","price_per_share":30.29,"price_display":"30.29","price_state":"stated","total_value":2990228.8,"total_display":"2,990,228.80","total_whole":"2,990,229","shares_owned_after":4968114.0,"shares_owned_after_display":"4,968,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-13","scope":"insider","n_lines":2},{"id":7809297,"accession":"0001209191-23-003293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003293","line_url":"/filing/0001209191-23-003293#line-2","is_derivative":false,"issuer_cik":"0001628098","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001628098","owner_cik":null,"owner_name":"Atlas Venture Opportunity Fund I, L.P.; Atlas Venture Associates Opportunity I, L.P.; ATLAS VENTURE ASSOCIATES X, L.P.; Atlas Venture Associates X, LLC; Atlas Venture Associates Opportunity I, LLC; Atlas Venture Fund X, L.P.","owner_display_name":"Atlas Venture Opportunity Fund I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21683.0,"shares_display":"21,683","price_per_share":29.96,"price_display":"29.96","price_state":"stated","total_value":649622.68,"total_display":"649,622.68","total_whole":"649,623","shares_owned_after":5045242.0,"shares_owned_after_display":"5,045,242","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-13","scope":"insider"}],"collapsed":true,"next_cursor":"2023-01-11|7809297","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Ten percent owner","n_filings":7,"first_seen":"2021-03-16","last_seen":"2024-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001816736","name":"Disc Medicine, Inc.","url":"/issuer/0001816736","role":"Ten percent owner","n_filings":5,"first_seen":"2023-08-16","last_seen":"2024-01-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Ten percent owner","n_filings":6,"first_seen":"2021-04-09","last_seen":"2021-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001681087","name":"AVROBIO, Inc.","url":"/issuer/0001681087","role":"Ten percent owner","n_filings":1,"first_seen":"2019-07-23","last_seen":"2019-07-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Magenta Therapeutics, Inc.","url":"/issuer/0001690585","role":"Ten percent owner","n_filings":1,"first_seen":"2019-03-22","last_seen":"2019-03-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742765","retrieved_at":"2026-08-24T08:29:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}